Fundamentals of Centrifugal Pump and System Interaction [PDF]
Short CoursePumps are an integral part of your industry, yet engineers, operators, and maintenance technicians are seldom fully trained to handle the pump problems they encounter daily.
Volk, Michael, Volk, Mike
core +1 more source
ENDOSCOPIC AND HISTOPATHOLOGIC GASTRIC CHANGES IN CHRONIC USERS OF PROTON-PUMP INHIBITORS
Background Proton-pump inhibitors have been used for at least two decades. They are among the most commonly sold drugs in the world. However, some controversy remains about the indications for their use and the consequences of their prolonged use ...
Sílvia Maria Perrone CAMILO +5 more
doaj +1 more source
Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors
Background Iron deficiency anemia without evidence for blood loss can present a diagnostic challenge. Proton pump inhibitors have been associated with iron deficiency anemia for many years, yet the relationship between the two until recently was not ...
Michael Boxer
doaj +1 more source
Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
Protein molecular machines, also known as proton pumps, are the most important element of biological membranes [...]
openaire +2 more sources
Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report
Background Hyponatremia is the most common electrolyte disorder. Thiazides, antidepressants, antipsychotic drugs, and antiepileptic drugs are well-known causes of hyponatremia. Proton pump inhibitor use is a rare cause of hyponatremia and, when reported,
Isabel J. B. van der Zalm +2 more
doaj +1 more source
Modified Rhodopsins From Aureobasidium pullulans Excel With Very High Proton-Transport Rates
Aureobasidium pullulans is a black fungus that can adapt to various stressful conditions like hypersaline, acidic, and alkaline environments. The genome of A. pullulans exhibits three genes coding for putative opsins ApOps1, ApOps2, and ApOps3.
Sabine Panzer +9 more
doaj +1 more source
The impact of drug-drug interactions between proton pump inhibitors and metformin: A systematic review of clinical evidence [PDF]
Metformin, a substrate of the organic cation transporters, is commonly co-prescribed with proton pump inhibitors, which inhibits these transporters. However, the clinical significance of this potential drug-drug interaction remains unclear.
Ria Andani Antong +3 more
doaj +3 more sources
Comparison of Proton Pump Inhibitor and Triple Therapy Regimen for Laryngospharyngeal Reflux Disease
Background: Laryngopharyngeal reflux is retrograde flow of contents of the stomach to the larynx and the pharynx. The study aims to compare two regimens (proton pump inhibitor monotherapy versus triple therapy) on the outcome of Helicobactor pylori ...
Apar Pokharel +2 more
doaj +1 more source
Overuse of proton pump inhibitors [PDF]
Proton pump inhibitors (PPIs) are currently the most effective drugs inhibiting hydrochloric acid secretion. They have replaced histamine type 2 receptor antagonists in the majority of clinical indications, for example, functional dyspepsia, gastroesophageal reflux disease, or drug‑induced upper gastrointestinal tract injury.
Dorota, Ksiądzyna +2 more
openaire +2 more sources
Background: Sweet’s syndrome, also referred to as acute febrile neutrophilic dermatosis, can either occur as an idiopathic disorder or associated with another condition, including cancer, or induced by exposure to a drug.
Philip R. Cohen
doaj +1 more source

